• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov8
Maxim Group analyst reiterates buy rating on Nephros
12:56
Nov7
Nephros released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 4.764 M (forecast USD 3.867 M), actual EPS USD 0.03 (forecast USD -0.02)
00:00
Nephros released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 14.06 M and EPS of USD 0.0999
00:00
Oct30
Nephros to Release FY2025 Q3 Earnings on November 6 After-Market (EST), Forecast Revenue USD 3.867 M, EPS USD -0.02
00:06
Aug7
Nephros released FY2025 Semi-Annual earnings on August 7 After-Market (EST), actual revenue USD 9.296 M, actual EPS USD 0.07
23:00
Nephros released FY2025 Q2 earnings on August 7 After-Market EST, actual revenue USD 4.419 M (forecast USD 3.601 M), actual EPS USD 0.02 (forecast USD -0.025)
23:00

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.764 M, Net Income 337 K, EPS 0.03

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.419 M, Net Income 237 K, EPS 0.02

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 4.877 M, Net Income 558 K, EPS 0.0499

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More